SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-051743
Filing Date
2020-09-23
Accepted
2020-09-23 20:30:30
Documents
2
Period of Report
2020-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3023
2 POA DOCUMENT poa.txt EX-24.3_938379 3615
  Complete submission text file 0001209191-20-051743.txt   8015
Mailing Address C/O AUDENTES THERAPEUTICS, INC. 101 MONTGOMERY ST., SUITE 2650 SAN FRANCISCO CA 94104
Business Address
PRASAD SUYASH (Reporting) CIK: 0001679129 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39536 | Film No.: 201193344

Mailing Address 7318 MORTON STREET DALLAS TX 75209
Business Address 7318 MORTON STREET DALLAS TX 75209 212.551.8702
Taysha Gene Therapies, Inc. (Issuer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)